ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury

[1]  F. Pelorosso,et al.  Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial , 2021, EClinicalMedicine.

[2]  A. Malhotra,et al.  SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2 , 2021, Circulation research.

[3]  P. Maes,et al.  STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters , 2020, Nature Communications.

[4]  L. Prokunina-Olsson,et al.  Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor , 2020, Nature Genetics.

[5]  S. Farhadian,et al.  Neuroinvasion of SARS-CoV-2 in human and mouse brain , 2020, bioRxiv.

[6]  Tokiko Watanabe,et al.  Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development , 2020, Proceedings of the National Academy of Sciences.

[7]  Ilya J. Finkelstein,et al.  Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes , 2020, bioRxiv.

[8]  L. Rodríguez-Mañas,et al.  Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study , 2020, The Lancet.

[9]  T. Hussain.  Faculty Opinions recommendation of Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. , 2020 .

[10]  A. Troxel,et al.  Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 , 2020, The New England journal of medicine.

[11]  Martin Stahl,et al.  Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 , 2020, Cell.

[12]  K. To,et al.  Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  K. Shi,et al.  Structural basis of receptor recognition by SARS-CoV-2 , 2020, Nature.

[14]  Fabian J Theis,et al.  SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues , 2020, SSRN Electronic Journal.

[15]  Fumihiro Kato,et al.  Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells , 2020, Proceedings of the National Academy of Sciences.

[16]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[17]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[18]  J. Penninger,et al.  B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction , 2020, Nature Communications.

[19]  B. Graham,et al.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.

[20]  Wenling Wang,et al.  The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice , 2020, Nature.

[21]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[22]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[23]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[24]  H. Katoh,et al.  Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in Japan , 2020 .

[25]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .

[26]  C. Wohlford-Lenane,et al.  Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration. , 2018, American journal of physiology. Lung cellular and molecular physiology.

[27]  Huadong Zhu,et al.  miRNA-200c-3p is crucial in acute respiratory distress syndrome , 2017, Cell Discovery.

[28]  Malarvizhi Gurusamy,et al.  Kinin B1 Receptor Antagonist BI113823 Reduces Acute Lung Injury* , 2015, Critical care medicine.

[29]  Wei Wang,et al.  Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury , 2014, Scientific Reports.

[30]  R. Gao,et al.  Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections , 2014, Nature Communications.

[31]  Thomas Walther,et al.  Angiotensin-(1–7) Protects From Experimental Acute Lung Injury , 2013, Critical care medicine.

[32]  J. Penninger,et al.  Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction , 2010, Circulation.

[33]  J. Penninger,et al.  Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy , 2009, Diabetes.

[34]  H. Iwasaka,et al.  Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models* , 2009, Critical care medicine.

[35]  Chengyu Jiang,et al.  Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2 , 2008, Virus Research.

[36]  N. Hooper,et al.  Tumor Necrosis Factor-α Convertase (ADAM17) Mediates Regulated Ectodomain Shedding of the Severe-acute Respiratory Syndrome-Coronavirus (SARS-CoV) Receptor, Angiotensin-converting Enzyme-2 (ACE2) , 2005, Journal of Biological Chemistry.

[37]  Mark Chappell,et al.  A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.

[38]  Arthur S Slutsky,et al.  Angiotensin-converting enzyme 2 protects from severe acute lung failure , 2005, Nature.

[39]  John L. Sullivan,et al.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.

[40]  Peter Cameron,et al.  A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.

[41]  Christian Drosten,et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[42]  Y. Guan,et al.  Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.

[43]  M. Crackower,et al.  Angiotensin-converting enzyme 2 is an essential regulator of heart function , 2002, Nature.

[44]  T. Parsons,et al.  Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase* , 2002, The Journal of Biological Chemistry.

[45]  Arthur S Slutsky,et al.  Comparison of lung protection strategies using conventional and high-frequency oscillatory ventilation. , 2001, Journal of applied physiology.

[46]  Nigel M. Hooper,et al.  A Human Homolog of Angiotensin-converting Enzyme , 2000, The Journal of Biological Chemistry.

[47]  K. Robison,et al.  A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9 , 2000, Circulation research.

[48]  X. Jeunemaître,et al.  Role of the renin-angiotensin system in blood pressure regulation and in human hypertension: new insights from molecular genetics. , 1995, Recent progress in hormone research.

[49]  L. Skeggs,et al.  The biochemistry of the renin-angiotensin system. , 1980, Advances in experimental medicine and biology.